Role of the gastrointestinal tract in establishing infection in primates and humans
- PMID: 19372940
- DOI: 10.1097/COH.0b013e3282f331b0
Role of the gastrointestinal tract in establishing infection in primates and humans
Abstract
Purpose of review: Here we present recent studies examining the gastrointestinal tract during primary HIV and simian immunodeficiency virus infections and emphasizing the onset of severe pathologic processes that are not adequately reflected in peripheral blood. We discuss these findings and hypotheses relating to the role of the gastrointestinal tract in HIV-1 pathogenesis.
Recent findings: High levels of viral replication in the gastrointestinal mucosa during primary HIV and simian immunodeficiency virus infections lead to severe depletion of effector memory CD4 T cells coinciding with increased immune activation and mucosal damage. Viral reservoirs established at this stage appear to be persistent over the course of infection and during therapy. In the simian immunodeficiency virus model of AIDS, onset of the impaired intestinal epithelial barrier function and renewal was observed during primary viral infection. Dysfunction of the mucosal immune system and the epithelial barrier may contribute to viral persistence and impaired responses to microbial pathogens in infected individuals.
Summary: A better understanding of the impact of HIV infection on the mucosal immune system may help in the development of newer preventive and therapeutic strategies directed against the virus.
Similar articles
-
Th17 cells, HIV and the gut mucosal barrier.Curr Opin HIV AIDS. 2010 Mar;5(2):173-8. doi: 10.1097/COH.0b013e328335eda3. Curr Opin HIV AIDS. 2010. PMID: 20543596 Review.
-
Mucosal immune dysfunction in AIDS pathogenesis.AIDS Rev. 2008 Jan-Mar;10(1):36-46. AIDS Rev. 2008. PMID: 18385779 Review.
-
Treatment of acute HIV-1 infection: are we getting there?Curr Opin HIV AIDS. 2008 Jan;3(1):67-74. doi: 10.1097/COH.0b013e3282f31d4b. Curr Opin HIV AIDS. 2008. PMID: 19372946
-
[Selected aspects of the immunopathogenesis of HIV infection].Klin Mikrobiol Infekc Lek. 2009 Aug;15(4):143-50. Klin Mikrobiol Infekc Lek. 2009. PMID: 19937578 Review. Czech.
-
Viral reservoirs and HIV-specific immunity.Curr Opin HIV AIDS. 2006 Mar;1(2):147-51. doi: 10.1097/01.COH.0000203831.78479.05. Curr Opin HIV AIDS. 2006. PMID: 19372799
Cited by
-
Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983-2018) With American Validation (1999-2018).Gastro Hep Adv. 2022;1(6):1114-1121. doi: 10.1016/j.gastha.2022.08.003. Epub 2022 Aug 11. Gastro Hep Adv. 2022. PMID: 36531445 Free PMC article.
-
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size.JCI Insight. 2024 Jul 9;9(16):e182312. doi: 10.1172/jci.insight.182312. JCI Insight. 2024. PMID: 38980725 Free PMC article. Clinical Trial.
-
Tissue-specific HIV-1 infection: why it matters.Future Virol. 2011 Jul;6(7):869-882. doi: 10.2217/fvl.11.48. Future Virol. 2011. PMID: 23946764 Free PMC article.
-
Immunology of pediatric HIV infection.Immunol Rev. 2013 Jul;254(1):143-69. doi: 10.1111/imr.12074. Immunol Rev. 2013. PMID: 23772619 Free PMC article. Review.
-
Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis.J Infect Dis. 2012 Sep 1;206(5):770-9. doi: 10.1093/infdis/jis422. Epub 2012 Jun 27. J Infect Dis. 2012. PMID: 22740713 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials